- Home
- TSBX vs PRTG Comparison
TSBX vs PRTG Comparison
Compare TSBX & PRTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSBX
- PRTG
- Stock Information
- Founded
- TSBX 2015
- PRTG 1973
- Country
- TSBX United States
- PRTG British Virgin Islands
- Employees
- TSBX N/A
- PRTG 7
- Industry
- TSBX
- PRTG Oil & Gas Production
- Sector
- TSBX
- PRTG Energy
- Exchange
- TSBX Nasdaq
- PRTG Nasdaq
- Market Cap
- TSBX 7.6M
- PRTG 17.7M
- IPO Year
- TSBX 2023
- PRTG N/A
- Fundamental
- Price
- TSBX $0.35
- PRTG $9.15
- Analyst Decision
- TSBX Buy
- PRTG
- Analyst Count
- TSBX 3
- PRTG 0
- Target Price
- TSBX $4.75
- PRTG N/A
- AVG Volume (30 Days)
- TSBX 77.6K
- PRTG 2.5M
- Earning Date
- TSBX 05-20-2025
- PRTG 05-13-2025
- Dividend Yield
- TSBX N/A
- PRTG N/A
- EPS Growth
- TSBX N/A
- PRTG N/A
- EPS
- TSBX N/A
- PRTG N/A
- Revenue
- TSBX N/A
- PRTG N/A
- Revenue This Year
- TSBX N/A
- PRTG N/A
- Revenue Next Year
- TSBX N/A
- PRTG N/A
- P/E Ratio
- TSBX N/A
- PRTG N/A
- Revenue Growth
- TSBX N/A
- PRTG N/A
- 52 Week Low
- TSBX $0.29
- PRTG $2.10
- 52 Week High
- TSBX $3.39
- PRTG $23.01
- Technical
- Relative Strength Index (RSI)
- TSBX 48.40
- PRTG 49.61
- Support Level
- TSBX $0.32
- PRTG $8.11
- Resistance Level
- TSBX $0.37
- PRTG $12.24
- Average True Range (ATR)
- TSBX 0.04
- PRTG 1.75
- MACD
- TSBX 0.00
- PRTG -0.27
- Stochastic Oscillator
- TSBX 74.07
- PRTG 6.73
About TSBX Turnstone Biologics Corp.
Turnstone Biologics Corp is a clinical-stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors. The company is pioneering a differentiated approach to tumor-infiltrating lymphocytes, or TILs, a clinically validated technology for treating solid tumors. It is developing next-generation TIL therapies by selecting the most potent and tumor-reactive T cells, which are referred to as Selected TILs. TILs are a type of cell therapy that harnesses the patient's own immune cells to target their own tumors. TIL therapy involves the isolation of lymphocytes from the patient's tumor, expansion of the isolated cells outside the body, and then infusion of the cells back into the patient.
About PRTG Portage Biotech Inc.
Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through clinical proof of concept with an initial focus on unmet clinical needs. It is an immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others.